C-Fos-Cre DREADD

Revision as of 10:16, 2 February 2023 by Houpt (talk | contribs) (→‎Mouse Strains: added C57BL/6J control strain)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Overview

Chemogenetic expression of DREADD receptors in c-Fos-positive cells after stimulation
Schematic timeline of recapitulating stimulation with excitatory DREADDs
Schematic timeline of attenuating stimulation with inhibitory DREADDs

Mouse Strains

Fos-CreER

Fos-tm2.1(icre/ERT2)Luo (JAX 030323)

hM3Dq

B6N;129-Tg(CAG-CHRM3*,-mCitrine)1Ute/J, aka CAG-LSL-Gq-DREADD (JAX 026220)

hM4Di

B6N.129-Gt(ROSA)26Sortm1(CAG-CHRM4*,-mCitrine)Ute/J, aka R26-LSL-Gi-DREADD (JAX 026219)

C57BL/6J (Controls)

C57BL/6J (JAX 000664)

Reagents

(Z)-4-Hydroxytamoxifen , Sigma-Aldrich H7904-5MG

Clozapine N-oxide (CNO) . APExBIO A3317 10mg

DMSO USP, Spectrum Chemical D1258-100ML

Sesame Oil, NF Spectrum Chemical SE130-500MLGL

Retrieved from "https://wiki.houptlab.org/index.php?title=C-Fos-Cre_DREADD&oldid=3058"